Genetics and epidemiology of Middle East Respiratory Syndrome-Coronavirus (MERS-CoV)
Authors
Abstract:
Background and aims: Middle East respiratory syndrome (MERS) is a viral respiratory illness caused by a coronavirus. After the primary onset of MERS in Saudi Arabia, in September 2015 cases began to increase. The number of laboratory-affirmed cases by MERS-CoV in the Middle East has been being increased recently. Methods: In this current review article, by using the terms “MERS” and “coronavirus” we first searched for English language articles in the PubMed database, published in last five years. Then by a detailed review of related articles, we provided a comprehensive information about epidemiology, genetic, host and coronavirus treatment. Results: More importantly, evidences of human-to-human transmission in Europe and America indicate that the viral adaptations in humans may precede a large-scale epidemic. The genome of Coronaviruses is a linear positive-sense single stranded large RNA and they are enveloped viruses that have a helical symmetric nucleocapsid. Some new insights have been provided in previous few months in to the animal Coronavirus hosts, transmissibility, contagion of MERS Co-V and ideal laboratory diagnostic methods. Conclusion: It seems crucial to control this new human infection “MERS-CoV” by collaborating global and local health authorities and their continual support for further research on it.
similar resources
Middle East Respiratory Syndrome Coronavirus (MERS-CoV): A Review Article
The recently emerged Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in the Middle East region in 2012. The virus is phylogenetically related to bat CoV, but other animal species like camels and goats may potentially act as an intermediate host by spreading the virus to humans. This virus is thought to cause a severe disease in patients with underlying comorbidities. Laboratory ...
full textgenetics and epidemiology of middle east respiratory syndrome-coronavirus (mers-cov)
background: middle east respiratory syndrome (mers) is a viral respiratory illness caused by a coronavirus. after the primary onset of mers in saudi arabia, in september 2015 cases began to increase. the number of laboratory-affirmed cases by mers-cov in the middle east has been being increased recently. method: in this current review article, by using the terms “mers” and “coronavirus” we firs...
full textUpdate on Middle East respiratory syndrome coronavirus (MERS-CoV).
Background: Since April 2012, Middle East Respiratory Syndrome Coronavirus (MERS-CoV) has been confirmed in 8 countries: France, Italy, Jordan, Qatar, Saudi Arabia, Tunisia, United Kingdom (UK) and United Arab Emirates (UAE). Of 55 laboratory-confirmed cases, 31 were fatal for a case fatality rate of 56% (current CDC data June 7, 2013). Although no cases have been reported in the US as of June ...
full textMiddle East Respiratory Syndrome coronavirus (MERS CoV): Update 2013.
Middle East Respiratory Syndrome coronavirus (MERS CoV) came to attention as an emerging pathogen causing severe respiratory illness in patients from the Middle East in September 2012. As of 14 June 2013, 58 human cases of MERS CoV infection have been confirmed, including 33 deaths (case fatality rate of 57%). MERS CoV is a beta-coronavirus, in the same family as SARS-CoV, and shares a probable...
full textUpdate: Recommendations for Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
On June 11, 2013, CDC issued interim infection prevention and control recommendations for hospitalized patients with known or suspected Middle East respiratory syndrome coronavirus (MERS-CoV) infection in U.S. hospitals. To date, no MERS-CoV cases have been reported in the United States; however, cases have been reported in eight other countries. Recent published reports have described limited ...
full textMy Resources
Journal title
volume 2 issue 4
pages 204- 208
publication date 2015-11-01
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023